For oncologists navigating the rapidly evolving landscape of renal cell carcinoma (RCC), the data presented at the 2026 ASCO ...

Endometrial cancer is the most common gynecologic cancer in the United States and is one of the few cancers in which survival ...

Molecular recurrence signals preceded symptoms or imaging in all recurrences observed, indicating ctDNA may enable earlier ...

Dr. Liangyou concluded his presentation discussing the efficacy and safety of disitamab vedotin combined with tislelizumab as adjuvant therapy after radical surgery for patients with HER2-expression ...

Patients treated with microwave ablation experienced significantly fewer postoperative complications and shorter hospital stays.

Advancing clinical development of VCN-01 for pancreatic ductal adenocarcinoma and retinoblastoma -- Licensed SYN-020 to Rasayana Therapeutics ...

The MarketWatch News Department was not involved in the creation of this content. Neuroendocrine Carcinoma Market Poised for Significant Growth During the Forecast Period (2026-2036) Driven by Rising ...

Women with stage IV breast cancer detected through screening have a 60% chance of survival ten years after diagnosis. This is in comparison to a survival rate of under 20% of those with stage IV ...

Advancements in treatments and more people getting screened have contributed to survival rates going up for cancers of all types. Trump says will require voter ID for midterms regardless of Congress ...